Report Categories
View AllRecent Articles
View All
SSAC SPACSphere earnings report shows no revenue as acquisition target search remains ongoing
PLPC Preformed shares drop 539 percent despite posting a 28 percent Q4 2025 earnings beat over analyst estimates
KALV KalVista Pharmaceuticals posts 291 Q4 2025 EPS surprise shares dip marginally in daily trading
RELX RELX PLC Q2 2025 EPS narrowly tops estimates shares gain 034 percent in todays trading